| 초록 |
Coenzyme Q10 has a central role in the generation of cellular bioenergy and its regulation, but its use is limited due to poor absorption profiles. We have developed a natural product based micelle formulation of CoQ10 (CoQ10-M), which appears water soluble and contains CoQ10. In this study, we tested its effect in experimental model of tacrolimus (TAC)-induced diabetes mellitus (DM). Rats were daily treated with TAC (1.5mg/kg, subcutaneous), oil-soluble CoQ10 (20mg/kg, P.O., CoQ10) and water-soluble CoQ10 (20mg/kg, P.O.) under 0.01% salt diet for 4weeks. After four weeks, there is no significant difference in body weight, water intake and 24hr-urine volume between the vehicle and another group. CoQ10 micelle treatment group further ameliorate hyperglycemia. IPGTT revealed that fasting blood sugar level was increased in TAC-treated groups, but it was reduced by CoQ10-M. TAC induced increased blood sugar level was also reduced by CoQ10-M in 30min, and this increase was persisted until 120min. CoQ10-M decreased the TAC-induced AUCg increasement. However, CoQ10 has no same effect. In addition, CoQ10-M further restored TAC-induced impaired islet than CoQ10. TAC-induced oxidative stress and apoptosis were also better inhibited by CoQ10 micelle compared with CoQ10. CoQ10-M decreased TAC-induced oxidative stress. In serum 8-OHdG ELISA, TAC treatment group was significantly increased 8-OHdG expression compared with VH group. The CoQ10-M group was obviously reduced the 8-OHdG expression. Furthermore, CoQ10-M decreased the apoptosis induced by tacrolimus. The number of positive cells in TUNEL staining in CoQ10-M group is less than TAC group. At the subcellular level, in TAC treatment group, number and the average size of mitochondria was decreased. CoQ10 -M increased the number and average size of mitochondria more than CoQ10. Water-soluble CoQ10 has a better effect on TAC-induced DM compared to oil-soluble CoQ10. |